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Methylmercury, an environmental 
electrophile capable of activation 
and disruption of the Akt/CREB/Bcl-2 
signal transduction pathway in  
SH-SY5Y cells
Takamitsu Unoki1,*, Yumi Abiko1,*, Takashi Toyama1,†, Takashi Uehara2, Koji Tsuboi1, 
Motohiro Nishida3,4, Toshiyuki Kaji5 & Yoshito Kumagai1
Methylmercury (MeHg) modifies cellular proteins via their thiol groups in a process referred to as  
“S-mercuration”, potentially resulting in modulation of the cellular signal transduction pathway. We 
examined whether low-dose MeHg could affect Akt signaling involved in cell survival. Exposure of 
human neuroblastoma SH-SY5Y cells of up to 2 μM MeHg phosphorylated Akt and its downstream 
signal molecule CREB, presumably due to inactivation of PTEN through S-mercuration. As a result, the 
anti-apoptotic protein Bcl-2 was up-regulated by MeHg. The activation of Akt/CREB/Bcl-2 signaling 
mediated by MeHg was, at least in part, linked to cellular defence because either pretreatment with 
wortmannin to block PI3K/Akt signaling or knockdown of Bcl-2 enhanced MeHg-mediated cytotoxicity. 
In contrast, increasing concentrations of MeHg disrupted Akt/CREB/Bcl-2 signaling. This phenomenon 
was attributed to S-mercuration of CREB through Cys286 rather than Akt. These results suggest that 
although MeHg is an apoptosis-inducing toxicant, this environmental electrophile is able to activate the 
cell survival signal transduction pathway at lower concentrations prior to apoptotic cell death.
Methylmercury (MeHg) exists as a naturally occurring substance or industrially produced environmental con-
taminant and is known to be a neurotoxicant that affects the central nervous system resulting in disorders such as 
Minamata disease in Japan and MeHg poisoning in Iraq1,2. MeHg-mediated toxicity is, at least in part, due to its 
electrophilic nature, which allows it to easily react with nucleophiles such as protein thiol groups, resulting in the 
disruption of cellular homeostasis through the S-mercuration of proteins3,4. We have reported that MeHg cova-
lently modifies a variety of proteins such as manganese superoxide dismutase (Mn-SOD), neuronal nitric oxide 
synthase (nNOS), arginase I, sorbitol dehydrogenase (SDH), and ubiquitin C-terminal hydrolase L1 (UCH-L1), 
resulting in their disruption5–9. In contrast, the environmental electrophile 1,2-naphthoquinone activates protein 
tyrosine phosphatase (PTP) 1B/epidermal growth factor receptor (EGFR) signalling, which is involved in cell 
survival, and kelch-like ECH-associated protein 1 (Keap1)/nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
signalling, which regulates phase-II xenobiotic detoxification enzymes and phase-III transporters associated with 
cellular protection against this electrophile through S-arylation of PTP1B and Keap110,11. These observations 
suggest that MeHg may also be associated with not only disruption of cellular homeostasis, but also activation of 
the cellular defence system at low doses through induction of electrophilic signal transduction pathways resulting 
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from S-mercuration of proteins. Consistent with this notion, we also found that MeHg activates Nrf2 through 
S-mercuration of Keap1 and up-regulates its downstream proteins, strongly suggesting that MeHg may activate 
other cellular signal transduction pathways. These observations led us to assume that MeHg exposure would 
result in a biphasic response with respect to cell death at high concentrations and survival at low concentrations.
Several lines of evidence have indicated that MeHg is a toxic metal that causes apoptosis in a variety of cells 
such as rat pheochromocytoma PC12s12, primary cultured rat granule neurons13, and human T-cells14, presuma-
bly through induction of apoptotic signaling. However, Chen et al.15 previously reported that MeHg is also able to 
activate Akt signaling at lower concentrations, possibly through generation of reactive oxygen species, although 
the mechanistic details were not provided.
Akt activation is negatively regulated by phosphatase and tensin homolog deleted from chromosome 10 
(PTEN)16. Once Akt is activated, a transcription factor cAMP response element-binding protein (CREB) under-
goes phosphorylation by activated Akt, thereby up-regulating one of its downstream genes, B-cell lymphoma 2 
(Bcl-2), an anti-apoptotic protein17–19. Our preliminary examination indicated that MeHg did cause Akt phos-
phorylation at a non-toxic concentration, whereas increasing concentrations of MeHg blocked Akt activation and 
resulted in concomitant apoptotic cell death in human neuroblastoma SH-SY5Y cells. Taken together, we hypoth-
esized that activation of such different signalling pathways associated with cell survival and cell death could be 
dependent on the examined concentration and thus covalent modification of cellular proteins by MeHg seems to 
play a role in the observed phenomena. To address this issue, we explored MeHg-mediated non-linear Akt/CREB/
Bcl-2 signal transduction and contribution of S-mercuration to modulation of the signaling.
Results
Activation of the Akt/CREB/BCl-2 signaling pathway by lower concentrations of MeHg in 
SH-SY5Y cells. When SH-SY5Y cells were exposed to 0.5 μ M MeHg for 6 h, the phosphorylated-Akt level 
was enhanced and Akt was translocated to the nucleus as evaluated by Western blotting (Fig. 1A) and immuno 
-histochemical assay (Fig. 1B). Under these conditions, globular actin was converted into its polymerized form 
(F-actin, Fig. 1B), suggesting a cellular response to MeHg. As shown in Fig. 2A,B, MeHg activated Akt in a time- 
and concentration- (up to 1 μ M) dependent manner as determined by western blot analysis. Under these con-
ditions, CREB was also phosphorylated during exposure to MeHg (Fig. 2A,B). MeHg up-regulated Bcl-2, an 
anti-apoptotic protein and CREB-target gene, through transactivation of the cAMP response element (CRE) 
(Fig. 2C). Under this condition, Glycogen synthase kinase-3β (GSK-3β ) was also phosphorylated and Nrf2 was 
activated by MeHg exposure (see Supplementary Fig. S1).
Pretreatment with either LY294002 or wortmannin, a specific inhibitor for phosphatidylinositol 3-kinase 
(PI3K), markedly inhibited MeHg-mediated phosphorylation of Akt and CREB and suppressed Bcl-2 protein 
expression (Fig. 3A). The MeHg-induced luciferase activity of CRE was also inhibited by wortmannin (Fig. 3B). 
These observations support that MeHg is able to activate the Akt/CREB/Bcl-2 signal transduction pathway at 
concentrations up to 1 μ M.
Figure 1. Translocation of phosphorylated Akt in the nucleus. SH-SY5Y cells were exposed to 0.5 μ M of 
MeHg for 6 h. Nuclear and cytoplasmic fractions were subjected to Western blotting with indicated antibodies. 
Nuclear Akt band intensity in control was defined as 100%. * p < 0.05 vs. control. Each value is the mean ± S.D. 
of three determinations (A). The localization of phosphorylated-Akt (p-Akt) (green) was detected along with 
F-actin (red) and the nucleus (blue). The regions enclosed by the white squares are magnified in the lower 
panels. Scale bars, 10 μ m. (B).
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Figure 2. Activation of Akt and CREB and induction of Bcl-2 by MeHg in SH-SY5Y cells. The cells were 
exposed to 1 μ M of MeHg for the indicated time and then were subjected to western blotting and the band 
intensities were quantified (A). The cells were exposed to the indicated concentrations of MeHg for 6 h. 
The whole lysates were subjected to western blotting and the band intensities were quantified (B). The cells, 
transfected with CRE-luciferase and the pRL-TK expressed vector, were exposed to 1 μ M of MeHg for the 
indicated time. The luciferase assay was performed as described in the materials and methods (C). * p < 0.05 vs. 
control. Each value is the mean ±  S.D. of three determinations.
Figure 3. Inhibition of the MeHg-mediated Akt/CREB/Bcl-2 signaling pathway by an Akt inhibitor in 
SH-SY5Y cells. SH-SY5Y cells were pretreated with wortmannin (0.5 μ M) for 30 min, and then the cells were 
exposed to MeHg for 12 h. The cells were also exposed to MeHg for 12 h in the presence or absence of LY294002 
(5 μ M). The whole cell lysates were subjected to western blotting and the band intensities were quantified (A). 
The cells were transfected with CRE-luciferase and then treated with wortmannin (0.5 μ M) for 30 min following 
exposure of MeHg for 6 h. The luciferase assay was performed as described in the materials and methods (B).  
* p < 0.05 vs. control MeHg (0 μ M). #p < 0.05 vs. control MeHg (0.5 μ M or 1 μ M). Each value is the mean ±  S.D. 
of three determinations.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:28944 | DOI: 10.1038/srep28944
Contribution of the MeHg-mediated Akt/CREB/Bcl-2 signaling pathway to cytotoxicity by 
MeHg in SH-SY5Y cells. To investigate whether or not up-regulation of Bcl-2 through activation of 
Akt/CREB signaling mediated by MeHg at lower concentrations could participate in substantial repression of 
MeHg-mediated apoptotic cell damage, histochemical determination and the MTT assay were carried out in 
SH-SY5Y cells with and without pretreatment of wortmannin. As shown in Fig. 4A,B, wortmannin treatment 
increased the number of propidium iodide positive cells and significantly decreased cell viability during exposure 
to MeHg. Knockdown of Bcl-2 also significantly accelerated MeHg-mediated cytotoxicity. These results suggest 
that activating the Akt/CREB signal transduction pathway caused by treatment with MeHg certainly diminishes 
late apoptosis and its cytotoxicity during MeHg exposure, indicative of a hormetic response.
Disruption of Akt/CREB/Bcl-2 signaling during exposure of SH-SY5Y cells to higher concentra-
tions of MeHg. As discussed herein and reported by others, there is little doubt that MeHg causes apoptotic 
cell death12–14. We therefore hypothesized that while MeHg can phosphorylate Akt and CREB leading to increased 
Bcl-2 protein at lower concentrations, this organometal may also disrupt Akt/CREB/Bcl-2 signalling at higher 
concentrations. As shown in Fig. 5A,B, activation of Akt mediated by MeHg reached a plateau at 5 μ M and then 
declined at 10 μ M in SH-SY5Y cells. However, while CREB and Bcl-2 were activated at 2 μ M MeHg, they were 
markedly blocked in the presence of higher concentrations of MeHg with no further increase in phosphorylation 
Figure 4. Protective role of Akt/CREB/Bcl-2 signaling in MeHg-induced cell death in SH-SY5Y cells. 
SH-SY5Y cells were pretreated with wortmannin (5 μ M) for 30 min and then the cells were exposed to MeHg 
(1 μ M) for 6 h. The cells were stained with annexin V and propidium iodide (PI). Scale bar, 50 μ m (A). The 
cells were pretreated with wortmannin (0.5 μ M) for 30 min following exposure of MeHg for 24 h, and then an 
MTT assay was performed (B). The cells were transfected with control, Bcl-2–1, or Bcl-2–2 siRNA for 48 h and 
the expression level of Bcl-2 was examined by western blotting (C, upper). The siRNA transfected cells were 
exposed to MeHg for 24 h, and then cell viability was measured by the MTT assay (C, lower). * p < 0.05 vs. 
control. Each value is the mean ±  S.D. of three determinations.
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and expression. A similar effect was also observed for treatment of MeHg on CRE-dependent luciferase activity 
in cells (Fig. 5C).
S-Mercuration of PTEN, Akt and CREB proteins. It is well recognized that oxidative modification and/or 
inhibition of PTEN is involved in the activation of Akt20–24. Because S-mercuration of PTEN is classified as an 
oxidation of thiol groups in PTEN, we speculated that MeHg-mediated activation of the Akt/CREB/Bcl-2 sig-
nalling pathway might be caused by inhibition of PTEN through S-mercuration and thus could be detected 
by modification using the biotin-PEAC5-maleimide (BPM)-precipitation assay25,26. As expected, a MeHg 
concentration-dependent decrease of BPM-labelled PTEN was observed (Fig. 6A,B) and activation of recombi-
nant human PTEN was significantly inhibited by MeHg (see Supplementary Fig. S2), suggesting that inhibition of 
PTEN activity may be attributed to S-mercuration of the protein by MeHg.
We previously found that the atmospheric electrophile 1,2-NQ covalently modifies CREB through reaction 
at Cys286, resulting in a repression of its DNA binding activity through CRE, thereby down-regulating Bcl-225,27. 
This finding led us to assume that because MeHg is electrophilic, it may also modify CREB. To address this 
issue, we performed the BPM-precipitation assay25,26. As shown in Fig. 6A,B, very little modification of Akt was 
Figure 5. Disruption of Akt/CREB/Bcl-2 signaling by higher concentrations of MeHg in SH-SY5Y cells. 
SH-SY5Y cells were exposed to MeHg (0, 2, 5, and 10 μ M) for 6 h, and subjected to western blotting (A) and the 
band intensities were quantified (B). The cells were transfected with CRE-luciferase and exposed to MeHg (0, 2, 
and 5 μ M) for 3 h. The luciferase assay was performed as described in the materials and methods (C).  
* p < 0.05 vs. control MeHg (0 μ M). #p < 0.05 vs. control MeHg (2 μ M). Each value is the mean ±  S.D. of three 
determinations.
Figure 6. S-Mercuration of Akt and CREB by MeHg in SH-SY5Y cells. SH-SY5Y cells were treated with 
MeHg for 3 h and a BPM-precipitation assay was performed. The precipitated proteins were detected by 
western blotting with the indicated antibodies (A). The cell lysate before the separation was used to estimate the 
alteration of protein expression by MeHg stimulation. The band intensities were quantified (B). Recombinant 
CREB (0.5 mg/mL) was reacted with MeHg (20 μ M) for 30 min at 37 °C, and then the proteins were subjected 
to SDS-PAGE following Coomassie brilliant blue staining (C, upper). The CREB protein on the gel was cut out 
using a gel-band cutter and the total Hg concentration in the CREB was analysed by AAS. The mercury content 
was expressed as Hg ng/ng of protein (C, lower). * p < 0.05 vs. control. Each value is the mean ±  S.D. of three 
determinations.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:28944 | DOI: 10.1038/srep28944
detected by MeHg, whereas CREB readily underwent S-mercuration by MeHg in a concentration-dependent 
manner. Nonreducing sodium dodecyl sulfide-polyacrylamide gel electrophoresis (SDS-PAGE), followed by 
atomic absorption spectrometry (AAS) analyses revealed that the Hg content resulting from covalent modifi-
cation wild-type of CREB by MeHg was significantly greater than that of the serine mutant of Cys286 (Fig. 6C), 
supporting that the site of covalent modification of CREB by MeHg is, at least partially, Cys286.
Discussion
The present study indicates that activation of the Akt/CREB/Bcl-2 signal transduction pathway in response to 
MeHg in SH-SY5Y cells does not increase linearly but rather follows a bell-shaped curve. These two distinct 
interactions of MeHg on the signal transduction pathways were related to the concentrations examined. For 
example, lower concentrations of MeHg (up to approximately 2 μ M) significantly modified PTEN, but not Akt 
(Fig. 6A,B), and activated Akt so that it is able to phosphorylate CREB which then up-regulates Bcl-2 through 
transactivation of CRE (Figs 1 and 2). Using specific inhibitors for PI3K, we concluded the activation of Akt/
CREB/Bcl-2 was mediated by MeHg (Figs 2 and 4). Pretreatments with wortmannin and Bcl-2 siRNA signifi-
cantly enhanced MeHg-mediated cell death (Fig. 4), suggesting that while MeHg is found to cause apoptosis12–14, 
MeHg-dependent activation of Akt/CREB/Bcl-2 signalling itself plays an important role in protection against 
apoptosis at lower concentrations. Interestingly, irradiation-mediated caspase 3/7 activation was significantly 
inhibited by MeHg at a lower concentration (0.5 μ M, 6 h), but not at higher concentrations (more than 2 μ M), 
when it was significantly blocked by pretreatment with wortmannin (see Supplementary Fig. S3). Thus, it seems 
likely that this MeHg-induced hormetic effect that acts to protect irradiation-dependent cytotoxicity results from 
activation of Akt/CREB/Bcl-2 signaling during 0.5 μ M MeHg exposure.
In contrast, MeHg at more than 2 μ M diminished phosphorylation of CREB, thereby down-regulating Bcl-2 
through blockage of CRE transactivation (Fig. 5). While CREB and Akt have 3 cysteine residues28 and 7 cysteine 
residues29, respectively, results from the BPM-precipitation assay indicated that CREB is more susceptible to MeHg 
than Akt in terms of S-mercuration mediated by MeHg (Fig. 6A,B). Previously, our matrix-assisted laser deso-
rption and ionization time-of-flight mass spectrometry analysis revealed the environmental electrophile 1,2-NQ 
is covalently bound to CREB through Cys286, Lys290 and Lys319 and that S-arylation of CREB through Cys286 
is essential for the blockage of DNA binding activity27, leading to a decreased level of Bcl-230. These observations 
suggested that the down-regulation of CREB during exposure of SH-SY5Y cells to MeHg at more than 5 μ M 
results from S-mercuration of this transcription factor at Cys286. Consistent with this notion, mutation of the 
cysteine to serine diminished covalent modification of CREB by MeHg (Fig. 6C). Overall, we speculate that cova-
lent modification of CREB by environmental electrophiles such as 1,2-NQ and MeHg through Cys286 disrupts 
its DNA binding activity. Three cysteines are located in the basic leucine zipper domain of CREB, which is crucial 
for its binding to CRE as a dimer31,32. Thus, S-mercuration of CREB through Cys286 may change its conformation 
leading to disruption of the DNA binding involved in substantial apoptosis in SY-SY5Y cells.
Akt is well known to be activated by inactivation of PTEN by reactive oxygen species or carbonyl com-
pounds33–35. Endogenous electrophiles such as Δ 12-prostaglandin J2 and 4-hydroxynonenal can activate Akt 
through modification of cysteine residues in PTEN36–38. Similarly, MeHg was able to modify cellular PTEN in 
SH-SY5Y cells (Fig. 6A) and also inhibited enzyme activity of recombinant PTEN (see Supplementary Fig. S2). 
This indicated that S-mercuration of MeHg, resulting in inhibition of PTEN contributes, at least partially, to the 
activation of Akt during exposure to lower concentrations of MeHg. We have identified other molecular targets 
(e.g., Mn-SOD, nNOS, arginase I, SDH, Keap1 and UCH-L1) of MeHg using cell-free systems incubated with 
MeHg, cultured cells exposed to MeHg and experimental animals treated MeHg5–9. Among them, UCH-L1 is a 
cellular protein candidate that may be associated with activation of Akt39–41. Further studies are required to iden-
tify sensor protein(s) that easily undergo S-mercuration by MeHg, thereby activating Akt.
Several lines of evidence have indicated that there are multiple possibilities for activation of Nrf2/antioxidant 
responsive element pathway42. We previously reported that S-mercuration of Keap1 protein, the negative regu-
lator of Nrf2, play a role in the substantial activation of Nrf2 in SH-SY5Y cells43,44. In the present examination, 
MeHg phosphorylated not only Akt but also GSK-3β during activation of Nrf2 mediated by MeHg in SH-SY5Y 
cells (Supplementary Fig. S1), suggesting that such a increased phosphorylation of GSK-3β may be, at least in 
part, involved in the Nrf2 activation caused by MeHg because GSK-3, which is inhibited by Akt, phosphorylates 
Ser residues in Neh6 domain of Nrf2 to form DpSGIpS motif-containing phosphodegron that is recognized by 
the β -transducin repeat-containing protein (β -TrCP)/Cul1-based E3 ubiquitin ligase complex (SCF), leading to 
degradation of Nrf245,46. In addition, Nrf2 is found to regulate Bcl-247, suggesting partial contribution of Nrf2 to 
up-regulation of Bcl-2 mediated by MeHg as well. Collectively, it is postulated that there is crosstalk for adaptive 
responses such as Akt and Nrf2 pathways induced by low-dose MeHg in SH-SY5Y cells.
Paracelsus (1493–1541), who was a scientist in addition to being doctor, introduced the concept that “poison 
is in everything… it is the dosage that makes something either a poison or a remedy”48. In other words, almost 
all chemicals have dual properties. The present study reports for the first time that MeHg causes a concentration 
specific activation (cell survival) and disruption (apoptosis) of the Akt/CREB/Bcl-2 signal transduction pathway 
in SH-SY5Y cells (Fig. 7). Although MeHg may also activate some apoptosis signal transduction pathways12–14, 
we postulated that the concentration-dependent S-mercuration of CREB, but not Akt, acts as a transducer of the 
MeHg effect, thereby repressing gene expression of the anti-apoptotic protein Bcl-2. We also speculate that acti-
vation of Akt/CREB/Bcl-2 signaling during exposure to MeHg at lower concentrations is, at least in part, involved 
in suppression of a threshold for MeHg-mediated cytotoxicity because blockage of Akt/CREB/Bcl-2 activation 
mediated by MeHg lowered the threshold for cytotoxicity.
www.nature.com/scientificreports/
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Methods
Materials and Methods. MeHg and avidin-agarose was obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Escherichia coli BL21 cells and trypsin were purchased from Promega Co. (Madison, WI, USA). Anti-
GAPDH antibody and anti-Lamin B1 antibody were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, 
CA, USA). Anti-G6PD antibody, BPM, 4,6-diamidino-2-phenylindole (DAPI), annexin V fluorescein isothiocy-
anate (FITC), and propidium iodide were obtained from Bethyl Laboratories (Montgomery, TX, USA), Dojindo 
(Kumamoto, Japan), Nacalai Tesque Inc. (Kyoto, Japan), MBL (Aichi, Japan), Wako Pure Chemical Industries 
(Osaka, Japan), respectively. Anti-Akt, anti-CREB, anti-phosphorylated Akt (Ser473), anti-phosphorylated CREB 
(Ser133), anti-Bcl-2, horseradish peroxidase (HRP)-conjugated anti-rabbit antibodies, LY294002, and wort-
mannin were purchased from Cell Signaling Technology (Beverly, MA, USA). Alexa 488-secondary antibody, 
rhodamine phalloidin and Lipofectamine 2000 were obtained from Thermo Fisher Scientific (MA, USA). All 
other reagents used were of the highest purity available.
Cells and cell culture. Human neuroblastoma SH-SY5Y cells were cultured in Dulbecco’s modified Eagle’s 
medium/Ham’s nutrient mixture F-12 with 10% fetal bovine serum, 2 mM L-alanyl-L-glutamine, and antibiot-
ics (100 U/mL penicillin, 100 μ g/mL streptomycin). Cultured cells were seeded at a density of 1 × 105 cells/cm2 
on a culture plate and maintained at 37 °C in a humidified incubator under an atmosphere of 5% CO2 and 95% 
ambient air. Before treatment, cells were cultured in serum-free medium overnight and then exposed to MeHg in 
serum-free medium to avoid MeHg binding to serum components.
Western blot analysis. The cells were exposed to MeHg and washed with Dulbecco’s phosphate-buffered 
saline (D-PBS), then collected into 2% SDS and heated at 95 °C for 20 min. The protein concentrations were meas-
ured using a BCA Protein Assay Kit (Piece, Rockford, IL, USA). Each sample was mixed with SDS-PAGE loading 
buffer [62.5 mM Tris-HCl (pH 6.8), 8% glycerol (v/v), 2% SDS (w/v), 0.005% bromophenol blue (w/v) and 5% 
2-mercaptoethanol (v/v)] and heated at 95 °C for 5 min. Proteins in the samples were separated by SDS-PAGE49 
and then were electro-transferred on to polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories, 
Hercules, CA, USA) at 2 mA/cm2 for 1 h, according to the method of Kyhse-Anderson50. After blocking with 5% 
skim milk, the membranes were incubated with primary antibodies and then incubated with secondary antibod-
ies coupled to HRP. Immunoreactive proteins were detected with a chemiluminescence system (Chemi-Lumi One 
L, Nacalai Tesque Inc.) and exposed to X-ray film (Konica Minolta Health Care Co., Tokyo, Japan). The bands 
were quantified using ImageJ software.
Nuclear and cytoplasmic extraction. After exposure to MeHg, the cells were washed twice with D-PBS. 
Then, nuclear and cytoplasmic extracts were obtained by using NE-PER Nuclear and Cytoplasmic Extraction 
Reagents Kit (Thermo Fisher Scientific) under the manufacturer’s instructions. Protein concentrations were 
determined by a BCA Protein Assay Kit (Piece). Each samples was loaded on a SDS-PAGE and detected by 
Western blot analysis as described above.
Purification of recombinant human UCH-L1 and CREB. Recombinant human CREB was purified as 
described previously27,30.
Thermal decomposition gold amalgamation atomic absorption spectrophotometry analysis. 
Mercury concentrations in the gels were analysed by thermal decomposition gold amalgamation atomic absorp-
tion spectrophotometry (Mercury analyzer MA-3000; Nippon Instruments Corporation, Tokyo, Japan). Briefly, 
CREB recombinant protein in the gel was cut out using a gel band cutter (Nippon Genetics, Tokyo, Japan). The 
obtained bands (6 × 3 × 1 mm, W × H × D) were heated at 180 °C for 120 sec and 850 °C for 120 sec to vaporize 
the mercury. The mercury content in the gels was corrected for the protein amount.
BPM-precipitation assay. The BPM assay was performed as described previously25. SH-SY5Y cells were 
seeded on a 60-mm dish and exposed to MeHg for 3 h. The cells were washed twice with D-PBS and then 
harvested with 1 mL of D-PBS. After centrifugation (5,000 × g for 5 min at 4 °C), the cells were lysed on ice 
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Figure 7. Biphasic regulation of Akt/CREB/Bcl-2 signaling mediated by MeHg. 
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for 20 min with 100 μ L of radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 8.0; 150 mM 
NaCl; 0.1% SDS; 0.5% deoxycholic acid; 1% NP-40) supplemented with protease inhibitors. The samples were 
incubated with BPM (20 μ M) for 30 min at 37 °C. The reaction mixtures were centrifuged at 15,000 × g for 
5 min at 4 °C and the supernatants were collected. BPM modified proteins were separated by addition of 50 μ 
L of avidin-agarose suspended in RIPA buffer and further incubated at 4 °C overnight. After centrifugation 
(15,000 × g for 5 min at 4 °C), the precipitated agarose beads were collected and washed with 1 mL of RIPA buffer 
twice. The beads were heated with 20 μ L of SDS-PAGE loading buffer at 95 °C for 20 min. After centrifugation 
at 5,000 × g for 5 min, the supernatants were subjected to SDS-PAGE and proteins were detected by western 
blotting as described above.
Knockdown of Bcl-2. The siRNA for human Bcl-2–1 (sense; 5′ -AUGCGGCCUCUGUUUGAUUtt-3′, antisense; 
5′-AAUCAAACAGAGGCCGCAUtt-3′), Bcl-2–2 (sense; 5′-GAGAUAGUGAUGAAGUACAtt-3′, antisense; 
5′-UGUACUUCAUCACUAUCUCtt-3′) and control siRNA (sense; 5′-UUCUCCGAACGUGUCACGUtt-3′, 
antisense; 5′ -ACGUGACACGUUCGGAGAAtt-3′) were transfected with Hiperfect according to the manufac-
turer’s instructions (Qiagen).
Immunohistochemistry. SH-SY5Y cells were cultured on a polyethylenimine-coated glass coverslips. After 
the exposure, the cells were washed with PBS, and fixed in 4% paraformaldehyde in PBS for 20 min. After the cells 
were washed with PBS and incubated with a blocking solution (2% BSA, 2% normal goat serum, and 0.4% Triton 
X-100 in PBS), phosphorylated Akt was labelled with the anti-phosphorylated Akt antibody (1:1000), and the 
proteins were visualized with Alexa 488-secondary antibody (1:1000). F-actin and the nucleus were also detected 
by rhodamine phalloidin (1:1000) and DAPI (0.1 μ g/mL). Then, the cells were washed with PBS, mounted in fluo-
rescent mounting medium (Dako Carpinteria, CA, USA) and observed using confocal laser scanning microscopy 
(ECLIPSE Ti, Nikon, Tokyo, Japan).
Luciferase assay. DNA transfections were performed using Lipofectamine 2000 according to the manu-
facturer’s instructions. Briefly, cells were cultured in 12 well plates. Two micrograms of CRE-luciferase expres-
sion vector and an internal control vector containing Renilla luciferase (pRL-TK, 0.2 μ g) were mixed with 
Lipofectamine 2000 to allow formation of the plasmid DNA-lipid complexes. After transfection, the cells were 
treated with MeHg, and the luciferase activity in the cellular extracts was measured by the Dual Luciferase 
Reporter Assay System (Promega) according to the manufacturer’s instructions.
Detection of apoptosis. SH-SY5Y cells were cultured in collagen-coated 8-well chamber plates. After pre-
treatment with or without 5 μ M of wortmannin for 30 min, the cells were exposed to 1 μ M of MeHg for 6 h. After 
washing with PBS, cells were incubated with annexin V FITC and propidium iodide in incubation buffer (10 mM 
HEPES [pH 7.4], 140 mM NaCl, 5 mM CaCl2) for 15 min. After washing with PBS, fluorescent images were cap-
tured using confocal laser scanning microscopy (ECLIPSE Ti, Nikon, Tokyo, Japan).
Cell viability. The 3-(4,5-dimethylthiazol-2-yl)-2,5-triphenyltetrazolium bromide (MTT) assay was used to 
estimate cell viability. The MTT assay was performed as described previously44.
Statistical analysis. The band intensities were quantified by ImageJ software, version 1.37. Statistical sig-
nificance was assessed by t-test (Fig. 6C) or two-way ANOVA followed by a Bonferroni posttest. All p values are 
two tailed.
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